| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/26/2006 | US7112404 Process for high throughput DNA methylation analysis |
| 09/26/2006 | US7112338 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 09/26/2006 | US7112337 Liposome mixture of a lipid that is neutral in charge at physiologic pH and positively charged at pH values less than physiological pH, and a lipid joined to a hydrophilic polymer by an aromatic disulfide linkage, associated with a nucleic |
| 09/26/2006 | US7112324 CD 19×CD3 specific polypeptides and uses thereof |
| 09/26/2006 | US7112321 Amyothropic lateral sclerosis; gene therapy |
| 09/26/2006 | US7112281 Underdrain for filtration membrane |
| 09/26/2006 | CA2345903C Molecular pathogenicide mediated plant disease resistance |
| 09/26/2006 | CA2283464C Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/26/2006 | CA2102624C Transmission-blocking vaccine against malaria |
| 09/21/2006 | WO2006099615A2 Adenoviral fiber exchange shuttle system |
| 09/21/2006 | WO2006099480A2 Stress proteins and peptides and methods of use thereof |
| 09/21/2006 | WO2006099369A2 Restoration of cholesterol independence and its use as a selectable marker in cell culture |
| 09/21/2006 | WO2006099353A1 Rnai-mediated inhibition of frizzled related protein-1 for treatment of glaucoma |
| 09/21/2006 | WO2006099249A2 Maize seed with synergistically enhanced lysine content |
| 09/21/2006 | WO2006099101A1 Immunogenic compositions for mucosal delivery |
| 09/21/2006 | WO2006099037A2 A sporadic tumor mouse model for drug discovery |
| 09/21/2006 | WO2006099021A2 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 09/21/2006 | WO2006099019A2 Methods and composition related to in vivo imaging of gene expression |
| 09/21/2006 | WO2006098998A2 Methods and compositions for modulating vascular integrity |
| 09/21/2006 | WO2006098952A2 Corn event 3272 and methods of detection thereof |
| 09/21/2006 | WO2006098929A1 Chimeric virus for the treatment of cancer |
| 09/21/2006 | WO2006098626A2 Resistance against parasitic weeds |
| 09/21/2006 | WO2006098523A1 Evaluation method for skin condition utilizing squamous cell carcinoma-related antigen as measure |
| 09/21/2006 | WO2006098520A1 Screening method |
| 09/21/2006 | WO2006098488A1 Method of ameliorating symptom caused by mood disturbance |
| 09/21/2006 | WO2006098485A1 Glutamate decarboxylase mutant |
| 09/21/2006 | WO2006098465A1 Prophylactic/therapeutic agent for cancer |
| 09/21/2006 | WO2006098463A1 Polynucleic acid-binding substance |
| 09/21/2006 | WO2006098435A1 Detecting chip and method of detecting substance using the same |
| 09/21/2006 | WO2006098428A1 Method of lessening nonspecific amplification from primer dimer |
| 09/21/2006 | WO2006098423A1 Polynucleotides imparting environmental stress-tolerance to plants |
| 09/21/2006 | WO2006098401A1 Method for determination of risk of rheumatoid arthritis |
| 09/21/2006 | WO2006098340A1 Molybdenum transporter and gene thereof |
| 09/21/2006 | WO2006098314A1 Novel sugar uptake activator and method for screening the same |
| 09/21/2006 | WO2006098225A1 Method of constructing plant having nodules with high nitrogen fixation activity |
| 09/21/2006 | WO2006098144A1 Detection marker, detection kit and detection method for idiopathic pulmonary fibrosis |
| 09/21/2006 | WO2006098074A1 Apoptosis inducing agent for prostate carcinoma cell |
| 09/21/2006 | WO2006098049A1 Gene detection method and gene detection kit utilizing photosensitization reduction reaction |
| 09/21/2006 | WO2006098040A1 Method for production of recombinant dna molecule |
| 09/21/2006 | WO2006097854A1 Heterodimeric meganucleases and use thereof |
| 09/21/2006 | WO2006097853A1 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 09/21/2006 | WO2006097787A1 Bovine cast gene snp and meat tenderness |
| 09/21/2006 | WO2006097784A1 I-crei meganuclease variants with modified specificity, method of preparation and uses thereof |
| 09/21/2006 | WO2006097748A2 Peptide stabilizer compounds and screening method |
| 09/21/2006 | WO2006097708A2 Affinity purification of protein |
| 09/21/2006 | WO2006097685A1 Improvements in or relating to control of gene expression in plants |
| 09/21/2006 | WO2006097636A1 Nucleic acid fragments and specific detection method by molecular identification of different bacteria species of the genus acinetobacter |
| 09/21/2006 | WO2006097465A2 Method for increasing a fungal resistance of transgenic plants by a host induced suppression of a pathogenic fungi genetic expression |
| 09/21/2006 | WO2006097464A1 Recombinant expression of defensins in filamentous fungi |
| 09/21/2006 | WO2006097462A2 Compositions and methods for treating inflammatory cns disorders |
| 09/21/2006 | WO2006097284A1 Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
| 09/21/2006 | WO2006097110A2 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 09/21/2006 | WO2006096985A1 Human endogenous retrovirus with foamy-like properties and uses thereof |
| 09/21/2006 | WO2006096973A1 Compositions and method for storage of nucleic acid from bodily fluids |
| 09/21/2006 | WO2006080934A3 Electroporation apparatus and methods |
| 09/21/2006 | WO2006077241A3 Kringle domains in a calcium sensor fusion protein |
| 09/21/2006 | WO2006073472A3 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples |
| 09/21/2006 | WO2006072607A3 Transplastomic plants free of the selectable marker gene |
| 09/21/2006 | WO2006070023A3 Method for reversing multiple resistance in animal cells |
| 09/21/2006 | WO2006067232A3 Plants having increased yield and method for making the same |
| 09/21/2006 | WO2006063462A9 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/21/2006 | WO2006058897A3 Plants having improved growth characteristics and method for making the same |
| 09/21/2006 | WO2006055487A3 Maize cr1bio gene promoter and its use to direct root-preferred transgene expression in plants |
| 09/21/2006 | WO2006046951A3 Cell cycle arrest and apoptosis |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006042848A3 Growth hormone conjugates |
| 09/21/2006 | WO2006031267A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 09/21/2006 | WO2006023635A3 Methods of screening proteins |
| 09/21/2006 | WO2006012393A3 Addition of transgenes into adenoviral vectors |
| 09/21/2006 | WO2005100383A8 Novel hiv+ infected cells targeting retroviral vectors and uses thereof for treatment of hiv infection |
| 09/21/2006 | WO2005089229A3 Vpac1 selective antagonists and their pharmacological methods of use |
| 09/21/2006 | WO2005080411A8 3’-terminal nucleoside unit containing phosphoramidite |
| 09/21/2006 | WO2005077105A3 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g) |
| 09/21/2006 | WO2005065339A3 Cell cycle genes and related methods of using |
| 09/21/2006 | WO2005047308A3 Peptide-based diagnostic reagents for sars |
| 09/21/2006 | WO2005037053A3 High throughput screening of aptamer libraries for specific binding to proteins on viruses and other pathogens |
| 09/21/2006 | WO2005019412A3 Mucosal immunization to prevent prion infection |
| 09/21/2006 | WO2005001057A3 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |
| 09/21/2006 | WO2004094616A3 Silencing transcription by methylation |
| 09/21/2006 | WO2004089282A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 09/21/2006 | US20060212973 Agrobacterium-mediated transformation of turfgrass |
| 09/21/2006 | US20060212972 Transformation method and transgenic plants produced thereby |
| 09/21/2006 | US20060212971 Nucleotide sequences mediating male fertility and method of using same |
| 09/21/2006 | US20060212970 Plant regulatory sequences for selective control of gene expression |
| 09/21/2006 | US20060212969 Nucleotide sequences coding enzymatic protein for use in the generation of disease and stress resistant plants |
| 09/21/2006 | US20060212968 High pigment golden beets |
| 09/21/2006 | US20060212967 For breeding highly efficient and stable antiviral transgenic plants |
| 09/21/2006 | US20060212966 Root-preferred, nematode-inducible soybean promoter and its use |
| 09/21/2006 | US20060212965 AXMI-018, AXMI-020, and AXMI-021, a family of delta-endotoxin genes and methods for their use |
| 09/21/2006 | US20060212964 Methods for enhancing insect resistance in plants |
| 09/21/2006 | US20060212963 Sequence-determined DNA fragments encoding ethylene responsive element binding proteins |
| 09/21/2006 | US20060212962 Sequence-determined DNA fragments encoding peptide transport proteins |
| 09/21/2006 | US20060212961 Rice transposon gene |
| 09/21/2006 | US20060212960 Manipulation of ascorbic acid levels in plants |
| 09/21/2006 | US20060212959 Transposase and method of gene modification |
| 09/21/2006 | US20060212958 cis-element of Oryzias Latipes Tol2 element (inverted terminal repeat sequences); plasmids |
| 09/21/2006 | US20060212957 TRANSGENIC NON-HUMAN MAMMAL WITH AN ONCOGENIC MUTANT OF THE c-Raf GENE 1 |
| 09/21/2006 | US20060212955 Transgenic mice containing lymphoid-specific GPCR gene disruptions |
| 09/21/2006 | US20060212953 Tr2, tr4, tr2/tr4 double knockouts and uses thereof |
| 09/21/2006 | US20060212952 Methods for cloning mammals using reprogrammed donor chromatin or donor cells |